![]() |
Adam McCudden is a Chartered Chemist and a Senior Scientist in AstraZeneca’s Pharmaceutical Technology and Development Group. Previously he has held positions in a range of research, development and technical roles for AstraZeneca, Eli-Lilly and Apollo Scientific. Through these roles, he has gained experience with most analytical techniques, but has specialised in the use of HPLC/UHPLC, NMR and Karl Fischer. Working in all stages of pharmaceutical R&D, from early lead identification to commercial life cycle management, stood him in good stead to lead the analytical R&D on the fastest pharmaceutical development programme in history. His current areas of focus are pharmaceutical product security (anti-counterfeiting) and leading or facilitating process understanding studies and investigations using statistical techniques and toolkits such as Six-sigma, Britest. |
Adam McCudden (Ordinary Member) |